Patents

 

As a result of our commitment to research and innovation, BrudyTechnology has obtained up to the date one European patent and two world patents, granted for the treatment of tumour diseases, dyslipidaemia and cellular oxidative damage.

 

Patente tumorales

 

Patent WO 2006120120 A1: Use of docosahexaenoic glycerides for the treatment of tumorous diseases

 

Patente HIV

 

Patent WO 2004050077 A1: Use of docosahexanoic acid as active substance for the treatment of lipodystrophy

 

Patente oxidación

 

Patent WO 2007/071733 A3: Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage